BNOX (Bionomics) Payments of Debt : $0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Bionomics Payments of Debt?

Bionomics's Payments of Debt for the three months ended in Sep. 2024 was $0.00 Mil.

Bionomics's Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Bionomics Payments of Debt Historical Data

The historical data trend for Bionomics's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionomics Payments of Debt Chart

Bionomics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Payments of Debt

Get a 7-Day Free Trial

-5.69

-8.92

-0.12

-0.11

Bionomics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Sep24
Payments of Debt	Get a 7-Day Free Trial															-0.03	-	-	-	-

Bionomics Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Bionomics Payments of Debt Related Terms

Thank you for viewing the detailed overview of Bionomics's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bionomics Ltd (NAS:BNOX) » Definitions » Payments of Debt

Comparable Companies

Traded in Other Exchanges

B1N0:Germany B1N0:Germany

Address

200 Greenhill Road, Eastwood, SA, AUS, 5063

Website

https://www.bionomics.com.au

Bionomics Ltd is a clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.